NEW YORK (GenomeWeb) – Biocept on Tuesday provided details regarding its previously announced plans to distribute subscription rights to certain shareholders of its common stock and warrants to purchase 25,000 securities units for a total of $25 million.

Biocept originally announced the distribution of the subscription rights in May. The subscription rights are being distributed to holders of common stock and warrants that Biocept issued Feb. 13, 2015; May 4, 2016; Oct. 19 2016; March 31, 2017; Aug. 9, 2017; and Jan. 30, 2018.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.